← All organizations

Cold Genesys, Inc.

For profitWebsite ↗

Also known as: CG Oncology, Inc | CG Oncology, Inc. | Cold Genesys | Cold Genesys, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 16, 2024

Timeline

2010s

Jan 1, 2010
Cold Genesys, Inc.— Founded

Drugs by trial phase (8 distinct, 9 trials)

Phase 3 (6 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

pembrolizumab

Phase 1 (1 own, 0 via acquisition)

nivolumab

Indications

Studied for

Recent trials (12)

NCT06443944Lead sponsorN/A—
NCT06567743Lead sponsorPhase 2Sep 16, 2024
NCT06111235Lead sponsorPhase 3Dec 14, 2023
NCT04452591Overall official - principal investigatorPhase 3Oct 27, 2020
NCT04452591Lead sponsorPhase 3Oct 27, 2020
NCT04610671CollaboratorPhase 1Oct 23, 2020
NCT04387461Overall official - principal investigatorPhase 2Jun 30, 2020
NCT04387461Lead sponsorPhase 2Jun 30, 2020
NCT02365818Lead sponsorPhase 2Jun 2, 2015
NCT02143804Lead sponsorN/AMay 19, 2014
NCT01438112Lead sponsorPhase 2/Phase 3Mar 1, 2014
NCT01438112Study chairPhase 2/Phase 3Mar 1, 2014

Details

Founded: Santa Ana, CA, US Jan 1, 2010
Last known activity: Sep 16, 2024